BCM
BML Capital Management Portfolio holdings
AUM
$131M
This Quarter Return
+14.7%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$131M
AUM Growth
+$131M
(+5.6%)
Cap. Flow
-$2.48M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
87.77%
Holding
29
New
1
Increased
10
Reduced
3
Closed
5
Top Buys
| 1 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$3.48M |
| 2 |
Instil Bio
TIL
|
$2.46M |
| 3 |
PMV Pharmaceuticals
PMVP
|
$1.33M |
| 4 |
Kezar Life Sciences
KZR
|
$1.04M |
| 5 |
Adverum Biotechnologies
ADVM
|
$678K |
Top Sells
| 1 |
AN2 Therapeutics
ANTX
|
$7.82M |
| 2 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$3.36M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$1.07M |
| 4 |
CNTB
Connect Biopharma
CNTB
|
$266K |
| 5 |
NextCure
NXTC
|
$131K |
Sector Composition
| 1 | Healthcare | 99.02% |
| 2 | Technology | 0.98% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Atea Pharmaceuticals
AVIR
$275M
| $27.4M | 20.73% |
7,609,812
| – | – |
|
|
THRD
2
DELISTED
Third Harmonic Bio
THRD
| $20.8M | 15.71% |
3,824,417
| – | – |
|
3
Aclaris Therapeutics
ACRS
$223M
| $20.2M | 15.31% |
14,250,000
| – | – |
|
|
4
Instil Bio
TIL
$196M
| $11.1M | 8.43% |
534,899
+118,179
| +28% | +$2.46M |
|
5
ESSA Pharma
EPIX
$11.2M
| $7.18M | 5.43% |
4,221,546
| – | – |
|
6
Oramed Pharmaceuticals
ORMP
$90.2M
| $6.94M | 5.25% |
3,083,253
+62,505
| +2% | +$141K |
|
|
7
Adverum Biotechnologies
ADVM
$68.2M
| $6.57M | 4.97% |
3,057,526
+315,209
| +11% | +$678K |
|
|
IMA
8
ImageneBio, Inc. Common Stock
IMA
$153M
| $5.4M | 4.09% |
4,030,102
+319,299
| +9% | +$428K |
|
|
9
PMV Pharmaceuticals
PMVP
$82.1M
| $5.3M | 4.01% |
5,000,000
+1,252,388
| +33% | +$1.33M |
|
|
ALMS
10
Alumis Inc. Common Stock
ALMS
$483M
| $3.63M | 2.75% |
1,210,415
+1,160,788
| +2,339% | +$3.48M |
|
|
11
Kezar Life Sciences
KZR
$28.5M
| $2.91M | 2.2% |
635,183
+227,045
| +56% | +$1.04M |
|
12
LAVA Therapeutics
LVTX
$41.3M
| $2.6M | 1.97% |
1,970,610
+10,000
| +0.5% | +$13.2K |
|
13
Milestone Pharmaceuticals
MIST
$151M
| $2.2M | 1.67% |
1,136,091
| – | – |
|
|
ELEV
14
DELISTED
Elevation Oncology
ELEV
| $2.16M | 1.64% |
5,890,434
-500
| -0% | -$184 |
|
|
CNTB
15
Connect Biopharma
CNTB
$111M
| $1.79M | 1.35% |
1,821,558
-271,674
| -13% | -$266K |
|
16
Astrotech Corp
ASTC
$8.45M
| $1.27M | 0.96% |
220,410
| – | – |
|
17
Athira Pharma
ATHA
$15.5M
| $976K | 0.74% |
3,230,667
+30,000
| +0.9% | +$9.06K |
|
18
Lisata Therapeutics
LSTA
$19.8M
| $608K | 0.46% |
209,814
-7,039
| -3% | -$20.4K |
|
19
Corvus Pharmaceuticals
CRVS
$419M
| $475K | 0.36% |
+118,766
| New | +$475K |
|
|
TSBX
20
DELISTED
Turnstone Biologics
TSBX
| $396K | 0.3% |
1,103,386
| – | – |
|
21
VistaGen Therapeutics
VTGN
$113M
| $300K | 0.23% |
150,000
| – | – |
|
22
HilleVax
HLVX
$105M
| $183K | 0.14% |
91,913
+71,153
| +343% | +$142K |
|
23
Verrica Pharmaceuticals
VRCA
$49.4M
| $92.6K | 0.07% |
174,651
| – | – |
|
|
ACHL
24
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| – | – |
-3,804,921
| Closed | – |
|
|
WHWK
25
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| – | – |
-1,890,245
| Closed | -$3.36M |
|